Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hypertonic Saline Nasal Irrigation and Gargling (HSNIG) for Suspected COVID-19: Pragmatic, Web-based Bayesian Adaptive Randomised Controlled Trial in Pakistan

NCT05104372 is registered in ClinicalTrials.gov with The Allergy and Asthma Institute, Pakistan as lead sponsor.

NCT NCT05104372
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05104372 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hypertonic Saline Nasal Irrigation and Gargling (HSNIG) for Suspected COVID-19: Pragmatic, Web-based Bayesian Adaptive Randomised Controlled Trial in Pakistan
Lead sponsor
The Allergy and Asthma Institute, Pakistan
Phase
Not applicable
Overall status
Unknown status
Start date
May 1, 2021
Completion date
November 30, 2021
Enrollment
405 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19